A detailed history of Nwi Management LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Nwi Management LP holds 100,000 shares of LLY stock, worth $87.4 Million. This represents 3.4% of its overall portfolio holdings.

Number of Shares
100,000
Holding current value
$87.4 Million
% of portfolio
3.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $1.09 Million - $1.4 Million
1,500 New
1,500 $1.16 Million
Q4 2023

Feb 15, 2024

BUY
$525.19 - $619.13 $31.5 Million - $37.1 Million
60,000 Added 200.0%
90,000 $52.5 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $9.32 Million - $10.9 Million
30,000 New
30,000 $10.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $830B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nwi Management LP Portfolio

Follow Nwi Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwi Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Nwi Management LP with notifications on news.